Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
095700.KQ Stock Summary
Top 10 Correlated ETFs
095700.KQ
In the News
095700.KQ Financial details
Company Rating
Buy
Market Cap
377.61B
Income
-66.87B
Revenue
4.43B
Book val./share
7156.17
Cash/share
1555.67
Dividend
-
Dividend %
-
Employees
98
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-3.8
Forward P/E
-0.35
PEG
12.32
P/S
56.63
P/B
1.26
P/C
5.81
P/FCF
-7.74
Quick Ratio
1.12
Current Ratio
1.54
Debt / Equity
0.23
LT Debt / Equity
0.08
-
-
EPS (TTM)
-1.67K
EPS next Y
-25497.3
EPS next Q
229
EPS this Y
-4.17%
EPS next Y
1425.96%
EPS next 5Y
1425.96%
EPS last 5Y
24.33%
Revenue last 5Y
-17.1%
Revenue Q/Q
316.43%
EPS Q/Q
-112.37%
-
-
-
-
SMA20
10.78%
SMA50
-5.96%
SMA100
16.02%
Inst Own
-
Inst Trans
-
ROA
-25%
ROE
-33%
ROC
-0.13%
Gross Margin
19%
Oper. Margin
-625%
Profit Margin
-1467%
Payout
-
Shs Outstand
41.45M
Shs Float
32.39M
-
-
-
-
Target Price
-
52W Range
7250.0-14640.0
52W High
-38.25%
52W Low
+24.69%
RSI
58
Rel Volume
0.55
Avg Volume
258.98K
Volume
141.23K
Perf Week
-2.16%
Perf Month
5.12%
Perf Quarter
2.26%
Perf Half Y
2.03%
-
-
-
-
Beta
0.906
-
-
Volatility
106.06%, 482.99%
Prev Close
-2.48%
Price
9040
Change
-0.44%
095700.KQ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 380.71 | 555.23 | 1.06K | 494.45 | 109.36 | |
Net income per share | -556.06 | 825.49 | -1.38K | -1.72K | -1.65K | |
Operating cash flow per share | -1.4K | -679.41 | -367.41 | -1.22K | -922.6 | |
Free cash flow per share | -1.57K | -1.4K | -2.01K | -2.19K | -1.1K | |
Cash per share | 2.78K | 201.02 | 801.26 | 672.25 | 1.59K | |
Book value per share | 10K | 16.04K | 14.92K | 8.46K | 7.33K | |
Tangible book value per share | 9.85K | 15.94K | 14.99K | 8.54K | 7.29K | |
Share holders equity per share | 10K | 16.04K | 14.92K | 8.46K | 7.33K | |
Interest debt per share | 1.47K | 921.6 | 1.57K | 2.67K | 1.77K | |
Market cap | 1427.38B | 3193.37B | 1555.7B | 465.75B | 418.13B | |
Enterprise value | 1447.71B | 3215.31B | 1580.12B | 531.89B | 479.52B | |
P/E ratio | -86.46 | 115.83 | -32.6 | -8.28 | -6.25 | |
Price to sales ratio | 126.28 | 172.21 | 42.24 | 28.86 | 94.46 | |
POCF ratio | -34.34 | -140.73 | -122.06 | -11.7 | -11.2 | |
PFCF ratio | -30.6 | -68.22 | -22.3 | -6.51 | -9.35 | |
P/B Ratio | 4.81 | 5.96 | 3 | 1.69 | 1.41 | |
PTB ratio | 4.81 | 5.96 | 3 | 1.69 | 1.41 | |
EV to sales | 128.08 | 173.39 | 42.9 | 32.96 | 108.33 | |
Enterprise value over EBITDA | -32.7 | -78.65 | -71.26 | -18.01 | -13 | |
EV to operating cash flow | -34.82 | -141.7 | -123.98 | -13.36 | -12.84 | |
EV to free cash flow | -31.03 | -68.69 | -22.65 | -7.43 | -10.72 | |
Earnings yield | -0.01 | 0.01 | -0.03 | -0.12 | -0.16 | |
Free cash flow yield | -0.03 | -0.01 | -0.04 | -0.15 | -0.11 | |
Debt to equity | 0.13 | 0.05 | 0.1 | 0.3 | 0.23 | |
Debt to assets | 0.11 | 0.05 | 0.08 | 0.22 | 0.18 | |
Net debt to EBITDA | -0.46 | -0.54 | -1.1 | -2.24 | -1.66 | |
Current ratio | 4.23 | 0.51 | 0.97 | 0.66 | 1.69 | |
Interest coverage | -10.17 | -11.45 | -11.17 | -10.34 | -10.03 | |
Income quality | 2.52 | -0.82 | 0.27 | 0.71 | 0.56 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.17 | 0.06 | 0.15 | 0.43 | |
Research and developement to revenue | 3.67 | 2.3 | 1.04 | 1.53 | 5.31 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | 0.12 | 1.06 | 4.47 | 0.8 | 0.2 | |
Capex to revenue | -0.45 | -1.3 | -1.55 | -1.97 | -1.67 | |
Capex to depreciation | -2.16 | -8.66 | -17.28 | -6.52 | -1.47 | |
Stock based compensation to revenue | 0.12 | 0.19 | 0.08 | 0.2 | 0.67 | |
Graham number | 11.19K | 17.26K | 21.49K | 18.12K | 16.5K | |
ROIC | -6.16 | -0.08 | -0.04 | -0.08 | -0.15 | |
Return on tangible assets | -0.05 | 0.05 | -0.08 | -0.15 | -0.18 | |
Graham Net | 150.2 | -1.41K | -2.27K | -2.1K | -4.39 | |
Working capital | 73.18B | -19.57B | -1.88B | -26.55B | 37.63B | |
Tangible asset value | 292.31B | 532.47B | 519.99B | 278.85B | 294.89B | |
Net current asset value | 34.55B | -39.73B | -56.32B | -55.49B | 12.48B | |
Invested capital | 0.13 | 0.05 | 0.1 | 0.3 | 0.23 | |
Average receivables | 0 | 7.51B | 7.25B | 9.87B | 16.24B | |
Average payables | 0 | 4.28B | 0 | 0 | 0 | |
Average inventory | 0 | -21.48B | 2.83B | 9.6B | 7.92B | |
Days sales outstanding | 169.74 | 192.1 | 46.96 | 339.17 | 1.44K | |
Days payables outstanding | 543.81 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | -2.64K | -60.95 | 340.88 | 496.92 | 164.93 | |
Receivables turnover | 2.15 | 1.9 | 7.77 | 1.08 | 0.25 | |
Payables turnover | 0.67 | 0 | 0 | 0 | 0 | |
Inventory turnover | -0.14 | -5.99 | 1.07 | 0.73 | 2.21 | |
ROE | -0.06 | 0.05 | -0.09 | -0.2 | -0.23 | |
Capex per share | -171.16 | -722.09 | -1.64K | -973.62 | -182.29 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 70.61 | 18.09 | 44.88 | 8.89 | 37.02 | |
Net income per share | -1.18K | -625.25 | -603.06 | -505.07 | 62.48 | |
Operating cash flow per share | -260.4 | -236.52 | -387.4 | -71.39 | -229.85 | |
Free cash flow per share | -544.98 | -250.38 | -399.23 | -199.48 | -255.33 | |
Cash per share | 671.25 | 2.3K | 1.96K | 2.17K | 1.56K | |
Book value per share | 8.45K | 8.81K | 7.86K | 7.1K | 7.16K | |
Tangible book value per share | 8.53K | 8.88K | 7.84K | 7.09K | 7.11K | |
Share holders equity per share | 8.45K | 8.81K | 7.86K | 7.1K | 7.16K | |
Interest debt per share | 2.6K | 1.97K | 1.86K | 1.97K | 1.66K | |
Market cap | 466.44B | 471.58B | 416.32B | 366.42B | 428.18B | |
Enterprise value | 532.58B | 463.07B | 431.67B | 444.77B | 489.57B | |
P/E ratio | -3.02 | -4.93 | -4.23 | -4.38 | 41.34 | |
Price to sales ratio | 202.09 | 681.56 | 227.3 | 994.3 | 279.01 | |
POCF ratio | -54.8 | -52.13 | -26.33 | -123.82 | -44.94 | |
PFCF ratio | -26.18 | -49.24 | -25.55 | -44.32 | -40.46 | |
P/B Ratio | 1.69 | 1.4 | 1.3 | 1.24 | 1.44 | |
PTB ratio | 1.69 | 1.4 | 1.3 | 1.24 | 1.44 | |
EV to sales | 230.74 | 669.26 | 235.68 | 1.21K | 319.02 | |
Enterprise value over EBITDA | -43.81 | -45.71 | -40.15 | -30.51 | -342.57 | |
EV to operating cash flow | -62.57 | -51.19 | -27.3 | -150.3 | -51.39 | |
EV to free cash flow | -29.9 | -48.36 | -26.49 | -53.79 | -46.26 | |
Earnings yield | -0.08 | -0.05 | -0.06 | -0.06 | 0.01 | |
Free cash flow yield | -0.04 | -0.02 | -0.04 | -0.02 | -0.02 | |
Debt to equity | 0.3 | 0.22 | 0.23 | 0.27 | 0.23 | |
Debt to assets | 0.22 | 0.17 | 0.18 | 0.21 | 0.18 | |
Net debt to EBITDA | -5.44 | 0.84 | -1.43 | -5.37 | -42.96 | |
Current ratio | 0.66 | 1.75 | 1.66 | 1.71 | 1.69 | |
Interest coverage | -13.48 | -11.74 | -12.36 | -17.77 | -2.03 | |
Income quality | 0.22 | 0.38 | 0.64 | 0.14 | -3.68 | |
Dividend Yield | 0.01 | 0.16 | 0.02 | 0 | 0 | |
Payout ratio | -0.14 | -3.1 | -0.27 | 0 | 0.01 | |
Sales general and administrative to revenue | 0.22 | 0.75 | 0.24 | 1.31 | 0.32 | |
Research and developement to revenue | 3.54 | 10.04 | 4.27 | 20.31 | 0.83 | |
Intangibles to total assets | 0.01 | 0 | 0 | 0 | 0.01 | |
Capex to operating cash flow | 1.09 | 0.06 | 0.03 | 1.79 | 0.11 | |
Capex to revenue | -4.03 | -0.77 | -0.26 | -14.41 | -0.69 | |
Capex to depreciation | -6.97 | -0.42 | -0.39 | -4.33 | -0.8 | |
Stock based compensation to revenue | 0.37 | 1.27 | 0.48 | 1.77 | 0.36 | |
Graham number | 14.99K | 11.13K | 10.32K | 8.98K | 3.17K | |
ROIC | -0.04 | -0.03 | -0.03 | -0.05 | 0 | |
Return on tangible assets | -0.1 | -0.05 | -0.06 | -0.05 | 0.01 | |
Graham Net | -2.1K | 179.59 | 75.89 | 219.38 | -4.28 | |
Working capital | -26.55B | 52.13B | 50.39B | 51.07B | 37.63B | |
Tangible asset value | 278.85B | 339.63B | 319.94B | 293.72B | 294.89B | |
Net current asset value | -55.49B | 23.81B | 30.99B | 25.96B | 12.48B | |
Invested capital | 0.3 | 0.22 | 0.23 | 0.27 | 0.23 | |
Average receivables | 14.64B | 14.99B | 16.01B | 16.42B | 16.65B | |
Average payables | 0 | 0.5 | 0.5 | 0 | 0 | |
Average inventory | 6.01B | 12.06B | 11.88B | 10.61B | 6.68B | |
Days sales outstanding | 584.76 | 1.95K | 837.5 | 3.86K | 1.03K | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 385.5 | 685.69 | 386.08 | 531.81 | 139.85 | |
Receivables turnover | 0.15 | 0.05 | 0.11 | 0.02 | 0.09 | |
Payables turnover | 0 | 1.59B | 0 | 0 | 0 | |
Inventory turnover | 0.23 | 0.13 | 0.23 | 0.17 | 0.64 | |
ROE | -0.14 | -0.07 | -0.08 | -0.07 | 0.01 | |
Capex per share | -284.58 | -13.86 | -11.83 | -128.09 | -25.49 |
095700.KQ Frequently Asked Questions
What is Genexine, Inc. stock symbol ?
Genexine, Inc. is a KR stock and trading under the symbol 095700.KQ
What is Genexine, Inc. stock quote today ?
Genexine, Inc. stock price is $9040 today.
Is Genexine, Inc. stock public?
Yes, Genexine, Inc. is a publicly traded company.